SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report Pursuant To Section 13 Or 15(d)
Of The Securities Exchange Act Of 1934
Date of Report November 10, 1998
------------------------
METRA BIOSYSTEMS, INC.
(Exact name of registrant as specified in its charter)
0-26234
(Commission File Number)
California 33-0408436
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
265 North Whisman Road
Mountain View, CA 94043
(Address of principal executive offices, with zip code)
(415) 903-9100
(Registrant's telephone number, including area code)
Item 5. Other Events
On November 4, 1998, Metra Biosystems, Inc., a California corporation (the
"Company") announced that the Board of Directors of the Company approved an
amendment of the Company's Preferred Shares Rights Agreement (the "Rights
Agreement") dated as of August 21, 1996, as amended, to add additional terms and
conditions to the definition of an Acquiring Person under the Rights Agreement.
Further details regarding this announcement are contained in the Company's press
release dated November 9, 1998 attached as an exhibit hereto and incorporated by
reference herein.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits.
Exhibit 99 Metra Biosystems, Inc. Press Release dated November 9, 1998.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
METRA BIOSYSTEMS, INC.
Date: November 10, 1998 By: /s/ GEORGE W. DUNBAR, JR.
-------------------------------------
George W. Dunbar, Jr.
President, Chief Executive Officer &
Chief Financial Officer
METRA BIOSYSTEMS, INC.
INDEX TO EXHIBITS
Sequential Page
Exhibit Number Description Number
-------------- ----------- ------
99 Press Release dated November 9,
1998